Introduction
Mesenchymal stem cells (MSCs) have exhibited potential for the treatment of ischemic heart diseases. Previous studies demonstrated that MSCs derived from the bone marrow can differentiate into cardiac myocytes in vitro and in vivo (1–3). Furthermore, it has been reported that MSCs transplanted into the acute ischemic heart and chronic congestive heart may modify cardiac function by promoting angiogenesis and reducing myocardial fibrosis (4–6). However, the therapeutic potential of MSCs is limited by their low survival rate following transplantation into damaged myocardium (7,8). A previous study revealed that <1% of MSCs were detected 24 h following transplantation into a rat heart with experimental myocardial infarction (MI) (9). Cell apoptosis, which is caused by the harsh hypoxic microenvironment, contributes to the low survival rate of transplanted MSCs (10,11). Therefore, the present study aimed to protect MSCs against apoptosis, in order to improve the therapeutic efficacy of MSCs transplantation.
Adrenomedullin (ADM) is a ubiquitous peptide synthesized by numerous cell types, including neurons, macrophages, monocytes, lymphocytes, and epithelial and endothelial cells (12–14). Although ADM was initially described as a potent vasodilator and hypotensive factor, numerous studies have reported that it may induce various biological activities in a paracrine or autocrine manner. It has been reported that ADM is not only able to enhance cell proliferation and angiogenesis (15–17), but can inhibit cell apoptosis (18). Furthermore, it has been demonstrated that ADM protects numerous cell types, including cardiomyocytes (19), rat Leydig cells (20), endothelial progenitor cells (21) and vascular endothelial cells (22), against apoptosis via the protein kinase B (Akt)/glycogen synthase kinase (GSK)3β signaling pathway. Akt is a powerful survival signal, which suppresses apoptosis and increases cell survival. Activation of Akt can trigger GSK3β phosphorylation (23), which subsequently results in an antiapoptotic effect via inactivation of caspase-3 (24,25). Furthermore, Akt has been reported to serve an important role in regulating B-cell lymphoma 2 (Bcl-2) family members (26). The Bcl-2 family members are important regulators of mitochondria-mediated apoptosis, and can be divided into anti-apoptotic proteins, such as Bcl-2, and proapoptotic proteins, including Bcl-2-associated X protein (Bax). The Bcl-2/Bax ratio is often used to determine the extent of apoptosis (27). Since the Akt signaling pathway has also been reported to serve an important role in mediating survival signaling in MSCs (28), the present study infected MSCs with ADM, and investigated whether ADM overexpression could protect MSCs from hypoxia and serum deprivation (H/SD)-induced apoptosis via the Akt/GSK3β and Bcl-2 signaling pathways.
Materials and methods
Culture and identification of MSCs
MSCs were isolated from the bone marrow of Sprague-Dawley rats (age, 4 weeks; weight, 60–80 g) according to a previously published method (29,30). Rats were obtained from the Laboratory Animal Science Department, The Second Affiliated Hospital of Harbin Medical University (Harbin, China). The rats were housed at a temperature of 22°C with a relative humidity of 40–70% and a 12-h light/dark cycle with food/water ad libitum. The present study was approved by the Local Ethics Committee for the Care and Use of Laboratory Animals of Harbin Medical University. Briefly, the femurs and tibias were removed from the rats, and the bone marrow was flushed out using 10 ml Dulbecco's modified Eagle's medium/F12 (DMEM/F12; HyClone; GE Healthcare, Logan, UT, USA) supplemented with 1% penicillin/streptomycin (Beyotime Institute of Biotechnology, Nantong, China). Following centrifugation at 1,000 × g at room temperature for 5 min, the resulting cell pellets were resuspended in 6 ml DMEM/F12 supplemented with 10% fetal bovine serum (FBS; ScienCell Research Laboratories, Inc., San Diego, CA, USA) and 1% penicillin/streptomycin, and were plated in a 25 cm2 plastic flask at 37°C in a humidified atmosphere containing 5% CO2 and 95% air. After a 48 h culture, the medium was replaced and non-adherent hematopoietic cells were removed. The remaining spindle-shaped, adherent cells were MSCs. These adherent MSCs were subsequently cultured; the culture medium was regularly changed every 3–4 days. A total of 7–10 days after seeding, the cells became 80–90% confluent. The adherent cells were released from the flask using 0.25% trypsin (Beyotime Institute of Biotechnology) and were expanded at a 1:2 or 1:3 dilution. A total of 9 Sprague-Dawley rats were used in the present study. For each primary cell culture, the bone marrow of 3 rats was mixed together. Passage 2 MSCs were cryopreserved and passage 3–4 MSCs were used in the present study. Primary cell culture was conducted three times, and cells in each primary culture were repeatedly used for subsequent experiments.
To investigate the expression of typical MSC-associated cell surface antigens, MSCs were analyzed by fluorescence-activated cell sorting (FACS). Briefly, MSCs were trypsinized and 1×106 MSCs were incubated with 10 µg antibodies in 1 ml PBS at room temperature in the dark for 15 min. The antibodies used in the present study were as follows: Hematopoietic progenitor marker phycoerythrin (PE)-conjugated mouse anti-rat cluster of differentiation (CD)34 (1:200; sc-74499; Santa Cruz Biotechnology, Inc., Dallas, TX, USA), the pan-leukocyte marker fluorescein isothiocyanate (FITC)-conjugated mouse anti-rat CD45 (1:100; MA5-17385; Caltag Laboratories, Inc., Burlingame, CA, USA), and the MSC marker PE-conjugated anti-rat CD29 (1:100; 102207; BioLegend, Inc., San Diego, CA, USA). To investigate differentiative ability, according to our previous study, MSCs were incubated with osteogenic induction medium (RAWMD-90021; Cyagen Biosciences, Santa Clara, CA, USA) or adipogenic induction medium (RAWMD-90021; Cyagen Biosciences) for 3 or 4 weeks. Subsequently, the cells were stained with von Kossa or Oil Red O (31). The staining results were observed by optical microscope.
Adenoviral transduction of MSCs
The MSCs were transduced with a recombinant adenoviral vector encoding the gene green fluorescent protein (Ad-CMV-GFP). For infection, MSCs were seeded in 6-well plates at 1×105 cells/well and were allowed to grow overnight to 50–60% confluence. Subsequently, the MSCs were infected with enhanced (E) GFP-recombinant adenovirus capsids (EGFP-Adv) or EGFP-recombinant adenovirus capsids containing ADM cDNA (EGFP-ADM) (BC061775; Shanghai GeneChem Co. Ltd., Shanghai, China) at a multiplicity of infection (MOI) of 80 at 37°C. After 12 h, the medium was replaced with normal medium containing 10% FBS and antibiotics. To confirm infection was successful, the mRNA expression levels of ADM were detected by reverse transcription-polymerase chain reaction (RT-PCR). Briefly, 24, 48 and 72 h post-infection, total RNA was isolated from the MSCs using TRIzol® reagent (Invitrogen; Thermo Fisher Scientific, Inc., Waltham, MA, USA). The β-actin gene was used as a normalizing control. The designed paired primers were as follows: ADM, forward 5′-GGACTTTGCGGGTTTTGC-3′, reverse 5′-TCTGGCGGTAGCGTTTGA-3′; and β-actin, forward 5′-ATATCGCTGCGCTCGTCGTC-3′ and reverse 5′-GCATCGGAACCGCTCATTGC-3′. PCR conditions were as follows: 25 cycles of denaturation at 94°C for 30 sec, annealing at 55°C for 30 sec and extension at 72°C for 1 min (initial denaturation at 94°C for 5 min; final extension is 72°C for 5 min). The PCR products were subjected to 1.5% agarose gel electrophoresis, and were scanned and semi-quantified using ImageQuant software (TL 7.0; GE Healthcare, Chicago, IL, USA). Based on these results, 48 h post-infection, the MSCs were used for subsequent experiments. Furthermore, 48 h post-infection, the infection rate was also assessed by fluorescence microscopy (DMI4000B; Leica Microsystems GmbH, Wetzlar, Germany) and FACS analysis with FACSDiva software (version 4.1; BD Biosciences, Franklin Lakes, NJ, USA). For FACS analysis, the MSCs at 48 h post-infection were digested and centrifuged at 1,000 × g for 5 min. After removing the supernatant, 500 µl PBS buffer was added and the MSCs were analyzed by flow cytometry.
H/SD model and cell groups
MSCs were randomly separated into the following six groups: Control, EGFP-Adv, EGFP-ADM, H/SD, EGFP-Adv + H/SD, and EGFP-ADM + H/SD.
To mimic the in vivo ischemic microenvironment, cells were cultured under H/SD conditions, according to a previous study (10). Briefly, 48 h post-infection, the cells in the EGFP-Adv + H/SD, EGFP-ADM + H/SD and H/SD groups were washed with PBS, cultured in serum-free medium and incubated in a glove box (855-AC; Plas-Labs, Inc., Lansing, MI, USA) to scavenge free oxygen at 37°C for an additional 12 h. The cells in the control, EGFP-Adv and EGFP-ADM groups were cultured in complete medium in a general cell incubator for 12 h. Subsequently, the following experiments were conducted.
Cell viability assay
The viability of MSCs was assessed using the Cell Counting kit-8 assay kit (CCK-8; Dojindo Molecular Technologies, Inc., Kumamoto, Japan) according to the manufacturer's protocol. Cells were seeded into a 96-well plate (5,000 cells/well) after being subjected to the aforementioned experimental treatments, and cell viability was measured following the addition of 10 µl CCK-8 into the culture medium for 1.5 h at 37°C. The absorbance of each well was quantified at 450 nm. The mean optical density (OD) of 5 wells in each group was used to calculate the percentage of cell viability. The experiments were conducted in triplicate.
Terminal deoxynucleotidyl transferase-mediated-dUTP nick-end labeling (TUNEL) staining
Apoptosis of MSCs was determined using a TUNEL assay (Roche Applied Science, Penzberg, Germany) according to the manufacturer's protocol with some modifications. Briefly, the MSCs were grown in a 24-well plate. Following the aforementioned experimental treatments, the cells were fixed in 4% paraformaldehyde for 1 h at room temperature. Subsequently, the cells (1×105 cells/well) were incubated with 3% H2O2 in methanol for 10 min at room temperature to block endogenous peroxidase activity, and were then incubated with 0.1% Triton X-100 in 0.1% sodium citrate for 2 min at 4°C. After washing in PBS, the cells were finally incubated with the TUNEL reaction mixture containing 5 µl enzyme solution and 45 µl fluorochrome-labeled solution at 37°C for 60 min in the dark. For counterstaining, the cells were incubated with DAPI (Beyotime Institute of Biotechnology) for 15 min. The cells were observed using a fluorescence microscope, in which 10 fields were randomly selected. The TUNEL+ and DAPI+ nuclei in the cells were counted manually. The percentage of positive cells was calculated as the apoptotic index (AI) using the following equation: AI = (number of positive cells/total number of cells) × 100%, as previously described (32,33). The experiments were conducted in triplicate.
Flow cytometric analysis of cell apoptosis
Apoptosis of MSCs was also determined by detecting phosphatidylserine exposure on cell plasma membranes using the fluorescent dye Annexin V-PE/7-aminoactinomycin D (7-AAD) apoptosis detection kit (BD Biosciences, San Diego, CA, USA) according to the manufacturer's protocol. This assay is used to discriminate between intact (Annexin V−/7-AAD−), early apoptotic (Annexin V+/7-AAD−), late apoptotic (Annexin V+/7-AAD+) and necrotic cells (Annexin V−/7-AAD+). Briefly, at the end of the treatment period, the cells were harvested with 0.25% trypsin and washed twice with cold PBS. After being resuspended in 100 µl 1X binding buffer, 5 µl Annexin V-PE and 5 µl 7-AAD were added, and the cells (4–5×105 cells) were incubated for 15 min at room temperature in the dark. Finally, 400 µl 1X binding buffer was added to the cells and flow cytometric analysis was conducted. The experiments were conducted in triplicate.
Protein extraction and western blot analysis
After washing with PBS twice, the treated cells were harvested and lysed in ice-cold radioimmunoprecipitation assay lysis buffer (Beyotime Institute of Biotechnology) mixed with protease and phosphatase inhibitors (Roche Applied Science). Total protein in the supernatant was quantified using a bicinchoninic acid protein assay kit (Beyotime Institute of Biotechnology). Equal amounts of protein (50 µg/lane) were separated by 12% SDS-PAGE and were transferred to polyvinylidene fluoride membranes. The membranes were then incubated at room temperature in a blocking solution composed of 5% skim milk powder dissolved in 1X TBS for 1 h at room temperature. Subsequently, the membranes were incubated with the following primary antibodies at 4°C overnight: Rabbit polyclonal antibodies against Bax (WL01637), Bcl-2 (WL01556), Akt (WL0003b) and GSK3β (WL01456) (all from Wanleibio Co., Ltd., Shanghai, China), rabbit polyclonal antibody against phosphorylated (p)-Akt (Ser-473) (sc-7985-R; Santa Cruz Biotechnology, Inc.), rabbit monoclonal antibody against p-GSK3β (Ser-9, 9322s), rabbit polyclonal antibody against caspase-3 (9662s) (both from Cell Signaling Technology, Inc., Danvers, MA, USA) and mouse polyclonal antibody against GAPDH (KC-5G4; Kangchen Bio-Tech Co., Ltd., Shanghai, China). The membrane was then washed three times with TBS-0.1% Tween (TBST) for 5 min followed by incubation with horseradish peroxidase-conjugated anti-mouse (ZB-2305; OriGene Technologies, Inc., Beijing, China) or anti-rabbit secondary antibodies (WLA023a; Wanleibio Co., Ltd.) for 60 min at 37°C. After further washes with TBST, immunoreactive bands were visualized using an enhanced chemiluminescence detection system (Bio-Rad Laboratories, Inc., Hercules, CA, USA). Image Pro Plus 5 software (Bio-Rad Laboratories, Inc.) was used to semi-quantify the protein levels in each lane.
Statistical analysis
Experimental values are presented as the means ± standard deviation, and the difference between groups was analyzed by one-way analysis of variance with Tukey's and Newman Keuls post hoc tests. The experiments were conducted in triplicate. Statistical analysis was performed using SPSS 19.0 software (IBM Corp., Armonk, NY, USA). P<0.05 was considered to indicate a statistically significant difference.
Results
Characterization and differentiation of cultured MSCs
Surface molecular markers of MSCs were examined after 3–4 passages using flow cytometry. As shown in Fig. 1A, 96.84% of isolated cells expressed CD29. Conversely, few cells expressed the hematopoietic markers CD34 (1.33%) and CD45 (18.08%) (Fig. 1A and B). In addition, as shown in Fig. 1C and D, the cultured MSCs possessed the ability to differentiate along the osteogenic and adipogenic lineages, as determined by von Kossa and Oil Red O staining, respectively.
EGFP-ADM infection increases the expression of ADM in MSCs
In the present study, infection efficiency was determined by detecting the positive rates of GFP fluorescence. Following infection with EGFP-Adv or EGFP-ADM for 48 h, ~100% of MSCs exhibited green fluorescence, which suggested that MSCs were successfully infected with the adenoviruses (Fig. 2A and B). Furthermore, to evaluate the mRNA expression levels of ADM in the genetically modified MSCs in vitro, RT-PCR analysis was performed on cell samples at 24, 48 and 72 h post-infection. The results demonstrated that the expression levels of ADM were markedly increased in the EGFP-ADM group as early as 24 h; the expression levels peaked at 48 h and were maintained until 72 h (Fig. 2C). Therefore, 48 h post-infection, the MSCs were used for subsequent experiments. Successful transduction at 48 h was also assessed by FACS analysis. As shown in Fig. 2D, >91% of MSCs were successfully transduced.
ADM increases MSC viability and proliferation
To investigate whether ADM protects MSCs against H/SD-induced injury, cell proliferation rate and viability rate were assessed using the CCK-8 assay. The cell viability rate was calculated using the following equation. Cell viability (%)=[OD (treated group) − A (blank)] / [ OD (control) − OD (blank)] ×100 The results detected no significant difference among the control (OD, 1.784±0.089; viability, 1±0), EGFP-Adv (OD, 1.696±0.066; viability, 0.947±0.036) and the EGFP-ADM-treated groups (OD, 1.656±0.015; viability, 0.923±0.046), thus indicating that adenovirus infection did not damage MSCs (Fig. 3). However, the proliferation and viability of MSCs was significantly decreased in the H/SD group (OD, 1.206±0.101; viability, 0.647±0.037) compared with in the control group (P<0.05). Conversely, the H/SD-induced impairments were markedly attenuated in the EGFP-ADM + H/SD group (OD, 1.457±0.062; viability, 0.802±0.061) compared with in the H/SD group (P<0.05), but not in the EGFP-Adv + H/SD group (OD, 1.154±0.109; viability, 0.615±0.028; P>0.05). These results suggested that ADM may protect MSCs against H/SD-induced injury (Fig. 3).
ADM protects MSCs from H/SD-induced apoptosis
DAPI and TUNEL staining were used to evaluate the protective effects of ADM on MSCs against H/SD-induced apoptosis. Briefly, modified or not modified MSCs were treated under H/SD conditions or normal conditions for 12 h; almost no TUNEL-positive cells were observed in the control (1.005±0.087), EGFP-ADM (1.179±0.165) and EGFP-Adv groups (1.091±0.079); however, cell shrinkage and nuclear condensation were markedly increased in the H/SD (6.683±0.178) and EGFP-Adv + H/SD groups (6.465±0.264) compared with in the control group (P<0.05), and no significant difference was detected between these two groups (P>0.05; Fig. 4). Notably, ADM transduction clearly exerted a protective effect on MSCs; the EGFP-ADM + H/SD group (3.428±0.229) possessed a significantly lower proportion of apoptotic cells compared with in the H/SD and EGFP-Adv + H/SD groups (P<0.05; Fig. 4).
In further studies, cell apoptosis was determined by flow cytometry. As shown in Fig. 5, the early apoptotic rate [Annexin V+/AAD−] was markedly increased in the H/SD (28.6±0.693) and EGFP-Adv + H/SD groups (29.667±1.857) compared with in the control (3.267±1.150; P<0.05), EGFP-ADM (3.433±1.709; P<0.05) and EGFP-Adv groups (3.067±1.266; P<0.05). In addition, there was no significant difference in the number of early apoptotic cells among the control, EGFP-ADM and EGFP-Adv groups (P>0.05). Notably, the EGFP-ADM + H/SD group (20.567±1.332) had a significantly lower proportion of cells in the early apoptotic phase compared with in the H/SD (P<0.05) and EGFP-Adv + H/SD groups (P<0.05); however, there were no differences in the number of cells in the late apoptotic phase (Annexin V+/AAD+) or necrosis (Annexin V−/AAD+) among the groups (data not shown). These findings indicated that overexpression of ADM in MSCs may protect against apoptosis under H/SD conditions.
Caspase-3 is a key effector protease associated with the execution of apoptosis. Under normal conditions, caspase-3 exists as inactivated procaspase-3. During apoptosis, procaspase-3 is activated and converted to cleaved caspase-3; therefore, the present study investigated the effects of ADM transduction on the expression of procaspase-3 and cleaved caspase-3. As shown in Fig. 6, the results demonstrated that the expression levels of cleaved caspase-3 were low in the control, EGFP-ADM and EGFP-Adv groups, according to the ratio of cleaved caspase-3/procas-pase-3 (control, 0.361±0.134; EGFP-ADM group, 0.305±0.098; EGFP-Adv group, 0.348±0.103). Conversely, the ratio of cleaved caspase-3/procaspase-3 was markedly increased in the H/SD (0.829±0.144) and EGFP-Adv + H/SD groups (0.789±0.055) compared with in the control group (P<0.05). Furthermore, the present results demonstrated that this increase was attenuated in the EGFP-ADM + H/SD group (0.469±0.077) compared with in the vs. H/SD group (P<0.05). There was no significant difference between the EGFP-ADM + H/SD and control groups (P>0.05).
ADM prevents MSCs from H/SD-induced apoptosis via the Akt/GSK3β pathway
The present study investigated the mechanisms underlying the antiapoptotic effects of ADM. As aforementioned, the Akt/GSK3β pathway has been reported to be important in promoting survival in various cell systems. Therefore, the present study investigated whether this pathway may mediate the antiapoptotic effects of ADM in MSCs by western blot analysis. As shown in Fig. 7A and B, compared with in the control (1.027±0.056), EGFP-Adv (1.025±0.079) and EGFP-ADM (1.074±0.097) groups, the ratio of p-Akt/Akt was significantly decreased in the H/SD (0.462±0.089; P<0.05) and EGFP-Adv + H/SD groups (0.369±0.098; P<0.05). However, the ratio of p-Akt/Akt was markedly increased in the EGFP-ADM + H/SD group (0.958±0.039) compared with in the H/SD (P<0.05) and EGFP-Adv + H/SD groups (P<0.05). In addition, no obvious difference was detected among the control, EGFP-Adv and EGFP-ADM groups (P>0.05). GSK3β is an important downstream target of the Akt signaling pathway. Phosphorylation of GSK3β at the inactivating residue serine-9 by Akt results in GSK3β inactivation. Therefore, the present study investigated the effects of ADM on p-GSK3β expression. As shown in Fig. 7A and B, H/SD treatment (H/SD, 0.322±0.043; EGFP-Adv + H/SD, 0.389±0.053) decreased p-GSK3β expression compared with in the control (0.752±0.062; P<0.05), EGFP-Adv (0.829±0.034; P<0.05) and EGFP-ADM groups (0.708±0.035; P<0.05), whereas the expression levels of inactivated p-GSK3β were significantly enhanced in the EGFP-ADM + H/SD group (0.732±0.042) compared with in the H/SD group (P<0.05). There was no significant difference between the EGFP-ADM + H/SD and control groups (P>0.05).
Antiapoptotic effects of ADM are involved in inhibition of the Bcl-2 pathway
Bcl-2 family members are important regulators of mitochondria-mediated apoptosis, and are classified as antiapoptotic proteins, such as Bcl-2, and proapoptotic proteins, such as Bax. The Bcl-2/Bax ratio is often used to determine the extent of apoptosis. The present results indicated that exposure of MSCs to H/SD conditions induced a significant decrease in the Bcl-2/Bax ratio (0.322±0.055) compared with in the control (0.954±0.033; P<0.05) and EGFP-Adv + H/SD groups (0.364±0.035; P<0.05). Conversely, the Bcl-2/Bax ratio was significantly increased in the EGFP-ADM (1.967±0.201) and EGFP-ADM + H/SD groups (1.371±0.039) compared with in the control (P<0.05) and H/SD (P<0.05) groups (Fig. 8).
Discussion
The present study demonstrated that ADM overexpression exerted antiapoptotic effects on MSCs under H/SD conditions, and indicated that the protective effects were mediated via the Akt/GSK3β and Bcl-2 signaling pathways.
Due to the self-renewal ability, multi-directional differentiation potential and low immunogenicity of MSCs, and the ease with which they can be transfected/transduced in order to express heterologous genes, MSCs are considered an ideal choice to treat MI (29,34). However, previous studies reported that only 1–5% transplanted cells survive 48 h post-transplantation (7,8). In addition, three mechanisms have been reported to mediate cell death following transplantation, including nutrient and oxygen deprivation, inflammation, and a lack of matrix support and adhesion to extracellular matrix (35–38). The present study focused on one of these mechanisms, with the aim of increasing cell survival under conditions of nutrient and oxygen deprivation. Therefore, in the present study, a model of H/SD was used to induce apoptosis of MSCs in vitro. Similar to the findings of previous studies (10,28–30), the present results demonstrated that the apoptosis of MSCs was significantly increased under H/SD conditions, thus indicating that the H/SD model may successfully mimic the in vivo microenvironment of nutrient and oxygen deprivation in MI.
There are various strategies that may be used to overcome the low survival rates of transplanted cells. These approaches include pretreatment with growth factors or cytokines, preconditioning with hypoxia, and genetic modification to overexpress antideath or adhesion signals (35,36). The majority of preclinical and clinical gene therapy applications have used virus-based transfer of genetic material, due to high transduction efficiency, cell tropism and levels of transgene expression; however, detrimental immune reactions against the gene therapy vehicle, and transduced cells or transgene products, has raised important concerns (39). Therefore, it is desirable to develop an efficient and safe carrier for gene transfection. Jo et al reported that a non-viral carrier of cationized polysaccharide may be used for genetic engineering of MSCs, and indicated that it is a promising strategy to improve the therapeutic effects of MSCs (40). In addition, compared with direct adenovirus-injection as unbound adenovirus, recombinant adenovirus modification, which has been reported to have no major influence on the immunological properties of MSCs in vitro and in vivo, has been considered a suitable gene vector for therapeutic applications of MSCs and has been extensively used for the genetic modification of MSCs (41). Therefore, recombinant adenovirus modification was used in the present study. As expected, the present results demonstrated that the adenovirus itself did not harm MSCs with an MOI of 80, since there was no difference in MSC proliferation and viability among the control, EGFP-Adv and EGFP-ADM groups. Therefore, it was concluded that EGFP-ADM transduction is a safe and effective method to protect MSCs against H/SD-induced apoptosis. In the future, we aim to investigate more carriers for genetic engineering of MSCs.
ADM has been confirmed as a hypoxia-induced peptide, which is found in various human cancers, as well as in cell lines, where it serves an antiapoptotic role (18,42). Therefore, overexpression of ADM in MSCs was generated, in order to study its effect on the apoptosis of MSCs in the present study. The results demonstrated that gene modification with ADM could protect MSCs from H/SD-induced apoptosis, since apoptosis of MSCs was significantly decreased in the EGFP-ADM + H/SD group compared with in the H/SD and EGFP-Adv + H/SD groups.
The underlying mechanisms were subsequently investigated. Akt is a serine-threonine kinase, which has been reported to act as a powerful survival signal that exerts antiapoptotic effects and promotes cell survival. Akt can phosphorylate various transcription factors and other regulatory proteins. GSK3β is an important downstream signaling protein kinase of Akt. Phosphorylation of GSK3β at serine 9 leads to inhibition of its activity and reduces apoptosis (23–25,43,44). Furthermore, Yin et al demonstrated that ADM could protect cardiomyocytes against ischemia/reperfusion injury-induced apoptosis via the Akt-GSK-caspase signaling pathway in a rat model (19). Based on these findings, it may be hypothesized that ADM exerts protective effects on MSCs under H/SD conditions via the Akt/GSK3β pathway. Therefore, in the present study, the phosphorylation of Akt and GSK3β were detected by western blotting. The results clearly indicated that H/SD successfully induced MSC apoptosis and decreased the expression of p-Akt and p-GSK3β, whereas pretreatment with EGFP-ADM attenuated the apoptosis of MSCs and increased the expression levels of p-Akt and p-GSK3β. Therefore, it may be concluded that ADM gene transduction protects MSCs against H/SD-induced apoptosis through the Akt/GSK3β pathway. Caspase-3 acts as a key effector of apoptosis. Under normal conditions, it is initially synthesized as inactive precursors. During the final step of the proapoptotic signaling pathway in numerous cell lines, caspase-3 is activated to form cleaved caspase-3. Cleaved caspase-3 is a crucial downstream factor within the apoptotic cascade, which functions as an important executor of apoptosis (45). The present results revealed that cleaved caspase-3 was markedly increased in the H/SD group compared with in the control group; however, this increase was attenuated in the EGFP-ADM + H/SD group compared with in the EGFP-Adv + H/SD group, thus indicating that ADM may protect MSCs through reducing the activation of caspase-3.
Proteins in the Bcl-2 family serve an instrumental role in regulating apoptosis by controlling mitochondrial permeability and the release of cytochrome c. This protein family includes antiapoptotic proteins, including Bcl-2 and Bcl-extra large (xL), and proapoptotic proteins, such as Bcl-2-associated death promoter (Bad), BH3 interacting-domain death agonist, Bax and Bcl-2-like protein 11. Bcl-2 resides in the outer mitochondrial wall, maintains membrane integrity and inhibits cytochrome c release. Conversely, Bax resides in the cytosol but translocates to the mitochondria following death signaling, where it damages membrane integrity and promotes release of cytochrome c. The Bcl-2/Bax ratio is often adopted to represent the extent of apoptosis (12). Furthermore, Bcl-2 family proteins have been reported to be associated with Akt/GSK3β. Bad is a well known substrate of Akt. In addition, p-Akt and p-GSK3β have been reported to upregulate the expression of Bcl-2 and Bcl-xL, and increase the Bcl-2/Bax ratio (46,47). Zhou et al confirmed that early administration of ADM significantly reduced apoptosis of vascular endothelial cells, increased Bcl-2 protein levels and decreased Bax gene expression (48). Therefore, the present study further examined whether the Bcl-2 pathway was also involved in the antiapoptotic activity of ADM. In the present study, the protein expression levels of Bcl-2 and Bax were detected. Notably, the present results demonstrated that ADM increased Bcl-2 protein expression and improved the Bcl-2/Bax ratio, regardless of hypoxic or normoxic conditions. Furthermore, although ADM could increase Bcl-2 protein expression under basal conditions, no effect was observed on the apoptotic rate between the control and EGFP-ADM groups, due to the low basal levels of apoptosis in MSCs. However, further investigation is required to elucidate the mechanisms underlying the effects of ADM on the increased expression of Bcl-2.
In conclusion, the results of the present study provided evidence to suggest that ADM promotes MSC survival under conditions mimicking myocardial ischemia. The prosurvival effects of ADM against H/SD-induced apoptosis may be mediated via the Akt/GSK3β and Bcl-2 signaling pathways.